Founded in 1996, APP Pharmaceuticals is a leading manufacturer of multi-source and branded injectable pharmaceutical products for acute medical care both in patient and ambulatory settings. Through continuous expansion of its’ broad portfolio of products covering a wide array of therapeutic categories, our products provide ongoing affordable healthcare helping millions of people in the United States and Canada fight critical illnesses
Headquartered in Schaumburg, Illinois, our 1,400 employees are united in their commitment to operations excellence in the ultimate effort to provide products that elevate patient care. APP, which was acquired by Fresenius Kabi Pharmaceuticals Holding, Inc. in September 2008, has offices in Canada and manufacturing operations in Illinois, New York and Puerto Rico. Fresenius Kabi Pharmaceuticals Holding trades on The Nasdaq Global Market under the symbol APCVZ.
|
It has come to our attention that reports have been circulating over the internet that APP Pharmaceuticals, LLC, has issued a recall of certain heparin products. APP would like to reassure our customers, and the patients they treat, that the reports are false and APP has not issued any recalls of its heparin products. Purported statements to the contrary are erroneous and not factual.
|
 |
 |
|
|
|
|
